524590 — Hemo Organic Income Statement
0.000.00%
Last trade - 00:00- IN₹36.22m
- IN₹50.87m
- IN₹24.14m
Annual income statement for Hemo Organic, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | PRESS |
| Standards: | IAS | IAS | — |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 0.048 | 0.224 | 24.1 |
| Cost of Revenue | |||
| Gross Profit | 0.031 | 0.071 | 2.15 |
| Selling / General / Administrative Expenses | |||
| Depreciation and Amortization | |||
| Other Operating Expenses | |||
| Total Operating Expenses | 0.594 | 2.69 | 24.6 |
| Operating Profit | -0.547 | -2.46 | -0.443 |
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | -0.547 | -2.64 | 0.256 |
| Provision for Income Taxes | |||
| Net Income After Taxes | -0.547 | -2.64 | 1.64 |
| Net Income Before Extraordinary Items | |||
| Net Income | -0.547 | -2.64 | 1.64 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | -0.547 | -2.64 | 1.64 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -0.16 | -0.76 | 0.47 |